Literature DB >> 21555762

Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.

Tsuyoshi Shimamura1, Nobuo Kubota, Saori Nagasaka, Taku Suzuki, Hideki Mukai, Kazutoshi Shibuya.   

Abstract

We developed a novel model of onychomycosis in which we observed fungi in the deep layer of the nail, and we used the model to evaluate the efficacy of two topical antifungal drugs. To establish an experimental, in vivo model of onychomycosis, we applied Trichophyton mentagrophytes TIMM2789 to the nails of the hind limbs of rabbits that underwent steroid treatment. The nails were taken from the rabbits' feet at 0, 2, and 6 weeks after a 2-week infection. The localization of the fungi was evaluated histopathologically. Some fungi were seen to penetrate to the nail bed, and the infection rate in the sample at 0, 2, and 6 weeks after infection was 57, 87, and 93%, respectively. In addition, fungi proliferated and moved proximally into the nail plate in a manner that depended on the duration of infection. Second, using this model we evaluated antifungal efficacy both by the culture recovery method and histopathological examination. Two topical antifungal drugs, 8% ciclopirox nail lacquer and 5% amorolfine nail lacquer, were applied to the nail for 4 weeks in each group. On histopathological examination, two antifungal treatment groups showed no significant difference against the nontreated control group. However, there were a significantly low fungus-positive rate and intensity of the recovery of fungi on culture between antifungal treatment and nontreated control groups. We therefore suggest that we have established an in vivo model of onychomycosis that is useful for the evaluation of the efficacy of antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555762      PMCID: PMC3122464          DOI: 10.1128/AAC.00399-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Onychomycosis; an experimental study.

Authors:  M CASANOVAS; J FRANCINO; X VILANOVA
Journal:  J Invest Dermatol       Date:  1956-08       Impact factor: 8.551

2.  The periodic acid-Schiff stain for the demonstration of fungi in animal tissue.

Authors:  A M KLIGMAN; H MESCON
Journal:  J Bacteriol       Date:  1950-10       Impact factor: 3.490

3.  Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.

Authors:  A K Gupta; N Konnikov; P MacDonald; P Rich; N W Rodger; M W Edmonds; R McManus; R C Summerbell
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

Review 4.  Onychomycosis.

Authors:  N Zaias
Journal:  Arch Dermatol       Date:  1972-02

5.  Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.

Authors:  Yoshiyuki Tatsumi; Mamoru Yokoo; Hisato Senda; Kazuaki Kakehi
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Patients at risk of onychomycosis--risk factor identification and active prevention.

Authors:  A Tosti; R Hay; R Arenas-Guzmán
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-09       Impact factor: 6.166

Review 7.  Onychomycosis in clinical practice: factors contributing to recurrence.

Authors:  R K Scher; R Baran
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

8.  Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly.

Authors:  D Reinel; C Clarke
Journal:  Clin Exp Dermatol       Date:  1992-09       Impact factor: 3.470

9.  Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly.

Authors:  J Lauharanta
Journal:  Clin Exp Dermatol       Date:  1992-09       Impact factor: 3.470

Review 10.  The dermatophytes.

Authors:  I Weitzman; R C Summerbell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

View more
  5 in total

Review 1.  Transungual permeation: current insights.

Authors:  Ronak S Bhuptani; Ketaki M Deshpande; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 2.  Relevant Animal Models in Dermatophyte Research.

Authors:  Ludivine Cambier; Marie-Pierre Heinen; Bernard Mignon
Journal:  Mycopathologia       Date:  2016-10-11       Impact factor: 2.574

Review 3.  Animal model of dermatophytosis.

Authors:  Tsuyoshi Shimamura; Nobuo Kubota; Kazutoshi Shibuya
Journal:  J Biomed Biotechnol       Date:  2012-04-29

Review 4.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Authors:  Patrick Van Dijck; Jelmer Sjollema; Bruno P Cammue; Katrien Lagrou; Judith Berman; Christophe d'Enfert; David R Andes; Maiken C Arendrup; Axel A Brakhage; Richard Calderone; Emilia Cantón; Tom Coenye; Paul Cos; Leah E Cowen; Mira Edgerton; Ana Espinel-Ingroff; Scott G Filler; Mahmoud Ghannoum; Neil A R Gow; Hubertus Haas; Mary Ann Jabra-Rizk; Elizabeth M Johnson; Shawn R Lockhart; Jose L Lopez-Ribot; Johan Maertens; Carol A Munro; Jeniel E Nett; Clarissa J Nobile; Michael A Pfaller; Gordon Ramage; Dominique Sanglard; Maurizio Sanguinetti; Isabel Spriet; Paul E Verweij; Adilia Warris; Joost Wauters; Michael R Yeaman; Sebastian A J Zaat; Karin Thevissen
Journal:  Microb Cell       Date:  2018-06-14

5.  Aloe-emodin-mediated antimicrobial photodynamic therapy against dermatophytosis caused by Trichophyton rubrum.

Authors:  Wenpeng Ma; Miaomiao Zhang; Zixin Cui; Xiaopeng Wang; Xinwu Niu; Yanyan Zhu; Zhihong Yao; Feng Ye; Songmei Geng; Chengcheng Liu
Journal:  Microb Biotechnol       Date:  2021-06-24       Impact factor: 5.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.